City snapshot: Haleon posts strong first half sales and profit growth after demerger

Panadol - More Laughs, Less Pain

Former GSK consumer arm Haleon has posted double-digit growth in its first financial results as a listed company, although it expects growth to slow in the second half

 

Already have an account? Sign in here

You’ve used up your article allowance

Sign up to read more stories for free

Register now